Table 1.

Viability of cells treated with various forms of PB NPs

Particle name	Method	Cell viability at a certain concentration	Ref.
PB@Bg-C3N4	In situ reduction	95.6% at 200 μg mL−1	[27]
NaDyF4:50%Lu@PB	Solvothermal method	86% at 1000 μg mL−1	[29]
HCPT@HPBNs@PAA/PAH/HA-g-PEG	Self-etching reaction and PEGylation by ECD-NHS reaction	56% at 30 μg mL−1	[61]
PEGylated PB NPs	Precipitation, thin film hydration method	84.2% at 40 μg mL−1	[62]
IBC-PB composites	Trituration and self-etching reaction	83.59% at 2500 μg mL−1	Our study

PB@ Bg-C₃N₄ a boracic-acid-modified graphite carbon nitride and Prussian blue nanohybrid, HCPT@HPBNs@PAA/PAH/HA-g-PEG 10-hydroxycamptothecin loaded hyaluronic acid grafting polyethylene glycol modified hollow Prussian blue nanoparticles, NaDyF₄:50%Lu@PB Prussian blue-coated NaDyF₄ doped with Lu³⁺ ions nanocomposites, PEGylated PB NPs polyethylene glycol-attached Prussian blue nanoparticles